Investments Akebia Therapeutics (NASDAQ: AKBA) Trades Higher on Disclosure of Insider Buying Akebia Therapeutics, Inc [NASDAQ: AKBA] closed last week on a high note. The stock gained by 21.6% to close the week at $4.21. This followed an SEC disclosure that two of the company’s directors, Cynthia Smith and Steven Gilman, had